Outcome and Summary of EGM held today i.e. 7th January, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemo Organic Ltd held an Extra-Ordinary General Meeting on 7th January 2026 via video conferencing from 4:10 PM to 4:25 PM, chaired by Managing Director Mr. Vishwambar Kameshwar Singh. Two key resolutions were transacted: (1) an Ordinary Resolution to increase the Authorised Share Capital and amend the Capital clause of the Memorandum of Association, and (2) a Special Resolution to issue warrants convertible into equity shares to non-promoter persons/entities on a preferential basis. Members were also given the opportunity to vote during the meeting, and the Chairperson confirmed that the voting results (combining remote e-voting and e-voting at the meeting) would be announced within two working days.
The combination of an authorised capital hike and a preferential issue of warrants to non-promoters strongly signals an upcoming fundraise, which could lead to equity dilution for existing shareholders. Shareholders should watch for the voting results and the subsequent pricing/disclosure of the warrant issue for clarity on the size of the fundraising and its impact on shareholding.